Travere Therapeutics Inc. (TVTX)
Travere Therapeutics Max Pain By Strike
TVTX trades at $18.76, 25.1% above the near-term max pain of $15 expiring Aug 15, 2025 (0 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$17.5), signaling increased put positioning or downside protection. Key magnetic zone at 15 where 4 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Travere Therapeutics Max Pain By Expiry
Max pain for TVTX shows a downward trend from 17.5 to 2.5, indicating bearish sentiment or hedging activity. The 114% spread signals divergent expectations across timeframes. Most levels below 18.76 may cap rallies. Strong magnetic level at 15 (4 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
Expiration Date | Max Pain | Max Pain vs Current Price |
---|---|---|
Aug 15, 2025 | 15 | -3.76 (-20.04%) |
Sep 19, 2025 | 17.5 | -1.26 (-6.72%) |
Oct 17, 2025 | 2.5 | -16.26 (-86.67%) |
Dec 19, 2025 | 15 | -3.76 (-20.04%) |
Jan 16, 2026 | 15 | -3.76 (-20.04%) |
Mar 20, 2026 | 12.5 | -6.26 (-33.37%) |
Apr 17, 2026 | 15 | -3.76 (-20.04%) |